HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Foot Dermatoses

Skin diseases of the foot, general or unspecified.

Also Known As:

Foot Dermatosis; Dermatoses, Foot; Dermatosis, Foot

Networked: 5 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Disease Context: Research Results

Skin and Connective Tissue Diseases
- Skin Diseases: 13127
  - Foot Diseases: 125
    - Foot Dermatoses: 5
      - Tinea Pedis: 475
      - Hereditary Papulotranslucent Acrokeratoderma: 1

Experts

1.	Abreu Velez, Ana Maria: 1 article (05/2015)
2.	Howard, Michael S: 1 article (05/2015)
3.	Pereyo, Neville: 1 article (05/2015)
4.	Chapman, Cindi N: 1 article (07/2014)
5.	Foster, Shannon K: 1 article (07/2014)
6.	Simpson, Brenda M: 1 article (07/2014)
7.	Simpson, Eric L: 1 article (07/2014)
8.	Davis, Mark D P: 1 article (06/2008)
9.	Kuhl, John T: 1 article (06/2008)
10.	McEvoy, Marian T: 1 article (06/2008)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Foot Dermatoses:

1.	Tissue Inhibitor of MetalloproteinasesIBA 05/01/2015 - "Immunohistochemical staining revealed positivity within the epidermis and/or lichenoid infiltrate with CD3, CD8, CD45, CD68, myeloid histiod antigen, BCL2, p27, p53, HLA-DPDQDR, metallothionein and tissue inhibitor of metalloproteinases 1. The diagnosis of PPLP was thus confirmed; this case illustrates that PPLP should be considered in the differential diagnosis of uncommon foot dermatoses with a significant junctional inflammatory component. "
2.	Methoxsalen (Oxsoralen)FDA Link 10/01/1999 - "8-MOP PUVA soak therapy is quite useful for chronic hand and foot dermatoses. "
3.	MetallothioneinIBA 05/01/2015 - "Immunohistochemical staining revealed positivity within the epidermis and/or lichenoid infiltrate with CD3, CD8, CD45, CD68, myeloid histiod antigen, BCL2, p27, p53, HLA-DPDQDR, metallothionein and tissue inhibitor of metalloproteinases 1. The diagnosis of PPLP was thus confirmed; this case illustrates that PPLP should be considered in the differential diagnosis of uncommon foot dermatoses with a significant junctional inflammatory component. "
4.	Ficusin (Psoralen)IBA 11/01/1994 - "The response to treatment of all patients enrolled over an 18-month period for localized oral or topical psoralen photochemotherapy (PUVA) of chronic hand and foot dermatoses was retrospectively reviewed. "
5.	AntigensIBA 05/01/2015 - "Immunohistochemical staining revealed positivity within the epidermis and/or lichenoid infiltrate with CD3, CD8, CD45, CD68, myeloid histiod antigen, BCL2, p27, p53, HLA-DPDQDR, metallothionein and tissue inhibitor of metalloproteinases 1. The diagnosis of PPLP was thus confirmed; this case illustrates that PPLP should be considered in the differential diagnosis of uncommon foot dermatoses with a significant junctional inflammatory component. "

Therapies and Procedures

1.	Therapeutics 07/01/2014 - "Grenz ray therapy seems to be a safe and effective modality for chronic hand and foot dermatoses with some patients experiencing prolonged remissions. " 10/01/1999 - "8-MOP PUVA soak therapy is quite useful for chronic hand and foot dermatoses. "
2.	PUVA Therapy 11/01/1994 - "The efficacy of localized PUVA therapy for chronic hand and foot dermatoses."
3.	Phototherapy (Light Therapy) 06/01/2008 - "Narrowband ultraviolet-B phototherapy for hand and foot dermatoses."
4.	Photochemotherapy (Photodynamic Therapy) 11/01/1994 - "The response to treatment of all patients enrolled over an 18-month period for localized oral or topical psoralen photochemotherapy (PUVA) of chronic hand and foot dermatoses was retrospectively reviewed. "